221 related articles for article (PubMed ID: 3356063)
1. Potentiation of cytotoxicity by 3-aminobenzamide in DNA repair-deficient human tumor cell lines following exposure to methylating agents or anti-neoplastic drugs.
Babich MA; Day RS
Carcinogenesis; 1988 Apr; 9(4):541-6. PubMed ID: 3356063
[TBL] [Abstract][Full Text] [Related]
2. Synergistic killing of virus-transformed human cells with interferon and N-methyl-N'-nitro-N-nitrosoguanidine.
Babich MA; Day RS
Carcinogenesis; 1989 Feb; 10(2):265-8. PubMed ID: 2463881
[TBL] [Abstract][Full Text] [Related]
3. Exogenous O6-methylguanine inhibits adduct removal and sensitizes human cells to killing by the chemical carcinogen N-methyl-N'-nitro-N-nitrosoguanidine.
Babich MA; Day RS
Mutat Res; 1987 Nov; 184(3):245-54. PubMed ID: 3670328
[TBL] [Abstract][Full Text] [Related]
4. Relationship of DNA repair phenotypes of human fibroblast and tumor strains to killing by N-methyl-N'-nitro-N-nitrosoguanidine.
Scudiero DA; Meyer SA; Clatterbuck BE; Mattern MR; Ziolkowski CH; Day RS
Cancer Res; 1984 Mar; 44(3):961-6. PubMed ID: 6692418
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment of normal human fibroblasts and human colon carcinoma cells with MNNG allows chloroethylnitrosourea to produce DNA interstrand crosslinks not observed in cells treated with chloroethylnitrosourea alone.
Zlotogorski C; Erickson LC
Carcinogenesis; 1983; 4(6):759-63. PubMed ID: 6861280
[TBL] [Abstract][Full Text] [Related]
6. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
Gibson NW; Zlotogorski C; Erickson LC
Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment of human colon tumor cells with DNA methylating agents inhibits their ability to repair chloroethyl monoadducts.
Zlotogorski C; Erickson LC
Carcinogenesis; 1984 Jan; 5(1):83-7. PubMed ID: 6690090
[TBL] [Abstract][Full Text] [Related]
8. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
9. Comparison of repair of O6-methylguanine produced by N-methyl-N'-nitro-N-nitrosoguanidine in mouse and human cells.
Yagi T; Yarosh DB; Day RS
Carcinogenesis; 1984 May; 5(5):593-600. PubMed ID: 6722979
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of alkylation-induced sister chromatid exchange frequency by 3-aminobenzamide is mediated by intracellular loss of NAD+.
Schwartz JL
Carcinogenesis; 1986 Jan; 7(1):159-62. PubMed ID: 3943137
[TBL] [Abstract][Full Text] [Related]
11. Adaptive resynthesis of O6-methylguanine-accepting protein can explain the differences between mammalian cells proficient and deficient in methyl excision repair.
Waldstein EA; Cao EH; Setlow RB
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5117-21. PubMed ID: 6957853
[TBL] [Abstract][Full Text] [Related]
12. Analysis of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced DNA damage in tumor cell strains from Japanese patients and demonstration of MNNG hypersensitivity of Mer xenografts in athymic nude mice.
Watatani M; Ikenaga M; Hatanaka T; Kinuta M; Takai S; Mori T; Kondo S
Carcinogenesis; 1985 Apr; 6(4):549-53. PubMed ID: 3986962
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.
Lunn JM; Harris AL
Br J Cancer; 1988 Jan; 57(1):54-8. PubMed ID: 2831926
[TBL] [Abstract][Full Text] [Related]
14. Induction of plasminogen activator by N-methyl-N'-nitro-N-nitrosoguanidine in mer+ and mer- human tumour cell strains.
Brdar B; Matulić M
Carcinogenesis; 1988 Dec; 9(12):2191-5. PubMed ID: 3191563
[TBL] [Abstract][Full Text] [Related]
15. A human cell line proficient in O6-methylguanine-DNA-methyltransferase and hypersensitive to alkylating agents.
Lefebvre P; Laval F
Carcinogenesis; 1993 Aug; 14(8):1671-5. PubMed ID: 8394782
[TBL] [Abstract][Full Text] [Related]
16. Contribution of O6-methylguanine-DNA methyltransferase to monofunctional alkylating-agent resistance in human brain tumor-derived cell lines.
Bobola MS; Blank A; Berger MS; Silber JR
Mol Carcinog; 1995 Jun; 13(2):70-80. PubMed ID: 7605582
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents.
Shiloh Y; Becker Y
Cancer Res; 1981 Dec; 41(12 Pt 1):5114-20. PubMed ID: 7307010
[TBL] [Abstract][Full Text] [Related]
18. Reduction of sister chromatid exchange frequency with time after mutagen exposure in Chinese hamster ovary cells in the presence of 3-aminobenzamide.
Schwartz JL; Morgan WF; Wolff S
Environ Mutagen; 1984; 6(2):203-10. PubMed ID: 6705757
[TBL] [Abstract][Full Text] [Related]
19. Isolation of clones displaying enhanced resistance to methylating agents in O6-methylguanine-DNA methyltransferase-proficient CHO cells.
Aquilina G; Frosina G; Zijno A; Di Muccio A; Dogliotti E; Abbondandolo A; Bignami M
Carcinogenesis; 1988 Jul; 9(7):1217-22. PubMed ID: 3383340
[TBL] [Abstract][Full Text] [Related]
20. The effects of pretreatment of human tumour cells with MNNG on the DNA crosslinking and cytotoxicity of mitozolomide.
Gibson NW; Erickson LC
Br J Cancer; 1985 Aug; 52(2):251-8. PubMed ID: 4027167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
